Status:
RECRUITING
Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered Service
Lead Sponsor:
Baylor College of Medicine
Collaborating Sponsors:
Centers for Disease Control and Prevention
London School of Hygiene and Tropical Medicine
Conditions:
Tuberculosis
HIV Coinfection
Eligibility:
All Genders
Phase:
NA
Brief Summary
Tuberculosis (TB) is the world's leading infectious cause of mortality and responsible for 1/3 of deaths in people living with human immunodeficiency virus (PLHIV). Children and adolescents living wit...
Eligibility Criteria
Inclusion
- OBJECTIVES 1 and 2:
- HIV positive or HIV exposed and presumptively positive while awaiting confirmatory testing in infants
Exclusion
- do not provide informed consent or assent as appropriate or are currently being treated for TB
- OBJECTIVE 3:
- Inclusion Criteria:
- negative TB symptom screen OR for whom TB disease has been ruled out in accordance with WHO Guidelines in adults and according to consensus definitions for child TB
Key Trial Info
Start Date :
July 11 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
6500 Patients enrolled
Trial Details
Trial ID
NCT05342064
Start Date
July 11 2023
End Date
September 1 2026
Last Update
October 21 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Baylor College of Medicine Children's Foundation
Mbabane, Eswatini
2
Baylor College of Medicine Children's Foundation
Maseru, Lesotho
3
Baylor College of Medicine Children's Foundation
Lilongwe, Malawi
4
Baylor College of Medicine Children's Foundation
Mbeya, Tanzania